Literature DB >> 4016733

Migration of tumor cells to organ-derived chemoattractants.

E S Hujanen, V P Terranova.   

Abstract

Certain tissues contain unique factors which are chemotactic for metastatic tumor cell lines. Extracts of bone, brain, liver, and lung were tested for their ability to promote either the migration or the chemoinvasion, i.e., their penetration through a reconstituted basement membrane barrier, of various metastatic tumor cells. Using a modified Boyden chamber assay for chemotaxis, B16-Br2 melanoma cells, which metastasize to brain, migrated most actively to brain extract. Lung-directed T241-PM2 fibrosarcoma cells migrated selectively to lung extract. Further, murine M50-76 reticulum cell sarcoma cells, which metastasize to liver and ovaries, were preferentially attracted to liver extract, and MCF-7 breast adenocarcinoma cells with high bone and brain colonization potential were found to migrate most actively to bone and brain extracts. Partial purification of tissue extracts showed that the factors in brain and liver are of different molecular weights. These data suggest that tissue-specific factors in different target tissues attract tumor cells which home to those sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016733

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials.

Authors:  Xue-Ning Ji; Sheng-Long Ye; Yan Li; Bo Tian; Jie Chen; Dong-Mei Gao; Jun Chen; Wei-Hua Bao; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-26       Impact factor: 4.553

2.  Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.

Authors:  S Aznavoorian; M L Stracke; H Krutzsch; E Schiffmann; L A Liotta
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

3.  Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.

Authors:  M Chackal-Roy; C Niemeyer; M Moore; B R Zetter
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Ovarian cancer cell invasion is inhibited by paclitaxel.

Authors:  A Westerlund; E Hujanen; M Höyhtyä; U Puistola; T Turpeenniemi-Hujanen
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

5.  The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants.

Authors:  A Albini; S L Aukerman; R C Ogle; D M Noonan; R Fridman; G R Martin; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

6.  The role of microenvironment in tumor angiogenesis.

Authors:  Domenico Ribatti; Angelo Vacca
Journal:  Genes Nutr       Date:  2008-04       Impact factor: 5.523

7.  Laminin production by murine melanoma cells: possible involvement in cell motility.

Authors:  S E Fligiel; K A Laybourn; B P Peters; R W Ruddon; J C Hiserodt; J Varani
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

8.  The role of the spleen in the organ-specific metastasis of murine BW 5147 T lymphomas.

Authors:  C Schmidt; H Verschueren; D Toussaint-Demylle; T van den Berg; G Kraal; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

9.  Differential organ tissue adhesion, invasion, and growth properties of metastatic rat mammary adenocarcinoma cells.

Authors:  G L Nicolson
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

10.  Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential.

Authors:  Tong-Chun Xue; Rong-Xin Chen; Dan Han; Jie Chen; Qiong Xue; Dong-Mei Gao; Rui-Xia Sun; Zhao-You Tang; Sheng-Long Ye
Journal:  Exp Ther Med       Date:  2011-09-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.